• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hong Kong, Cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital (September 10 2012)

Giuseppe

Emeritus
[Source: Hospital Authority, Hong Kong PRC SAR, full text: (LINK).]

Cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital


The following is issued on behalf of the Hospital Authority:

The spokesperson for Queen Elizabeth Hospital (QEH) made the following announcement today (September 10):

A 74-year-old male stroke patient admitted to the Department of Medicine at QEH earlier was confirmed to be a Vancomycin Resistant Enterococci (VRE) carrier on September 6.

In accordance with the prevailing infection control guidelines, the hospital has screened patients who had contact with the index patient.

Three male patients (aged 56 to 78) have been confirmed to be VRE carriers, all without clinical symptoms. Three of the patients are hospitalised at QEH and the reminding one was transferred to Kowloon Hospital for further treatment on August 25. All are in stable condition, under medical surveillance and isolation.

The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow-up.

The Hospital Infection Control Team, the department concerned and experts of the Centre for Health Protection had a meeting today and the following enhanced infection control measures have already been adopted:
  1. All VRE carriers are being treated in isolation rooms or cohorts according to their clinical symptoms and treatment needs;
  2. Visiting is limited to two people per patient during each visiting period; and
  3. Stringent contact precautions have been applied, including dedicated use of clinical items to VRE carriers and enhanced hand hygiene and environmental hygiene.
The Hospital Infection Control Team will continue to closely monitor the situation of the ward.


Ends/Monday, September 10, 2012
Issued at HKT 19:34
NNNN
-
-------
 
Re: Hong Kong, Cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital (September 10 2012)

[Source: Hospital Authority, Hong Kong PRC SAR, full text: (LINK).]

Update on cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital


The following is issued on behalf of the Hospital Authority:

Regarding the confirmation earlier that there were in-patients found to be Vancomycin Resistant Enterococci (VRE) carriers, the spokesperson for Queen Elizabeth Hospital gave the following update today (September 11):

In accordance with the prevailing infection control guidelines, screening of contacts has been performed.

Today, three male patients (aged 79 to 89) were confirmed as VRE carriers, without clinical symptoms, during contact tracing. All are in stable condition and have been transferred to Kowloon Hospital for further treatment.

The hospital will continue the enhanced infection control measures and closely monitor the situation.

The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow-up.

Ends/Tuesday, September 11, 2012
Issued at HKT 16:04
NNNN
- -------
 
Re: Hong Kong, Cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital (September 10 2012)

[Source: Hospital Authority, Hong Kong PRC SAR, full text: (LINK).]

Update on cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital


The following is issued on behalf of the Hospital Authority:

Regarding the confirmation earlier that there were in-patients found to be Vancomycin Resistant Enterococci (VRE) carriers, the spokesperson of Queen Elizabeth Hospital made the following update today (September 13):

In accordance with the prevailing infection control guidelines, screening of contacts has been performed.

Two male patients (aged 79 and 88) were confirmed as VRE carriers, without clinical symptoms, today during the contact tracing.

One of them is in stable condition and has been transferred to Kowloon Hospital for further treatment. Another patient succumbed on September 11 because of other illness.

The hospital will continue the enhanced infection control measures and closely monitor the situation.

The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow-up.


Ends/Thursday, September 13, 2012
Issued at HKT 18:20
NNNN
- ------
 
Re: Hong Kong, Cluster of Vancomycin Resistant Enterococci cases in Queen Elizabeth Hospital (September 10 2012)

[Source: Hospital Authority, Hong Kong PRC SAR, full page: (LINK).]

Cluster of Vancomycin Resistant Enterococci cases at Queen Elizabeth Hospital


The following is issued on behalf of the Hospital Authority:

The spokesperson for Queen Elizabeth Hospital (QEH) made the following announcement today (September 17):

A 29-year-old male patient admitted to the Department of Neurosurgery at QEH due to brain tumour was confirmed to be a Vancomycin Resistant Enterococci (VRE) carrier on September 7.

In accordance with the prevailing infection control guidelines, the hospital has screened patients who had contact with the index patient.

Four male patients (aged 51 to 100) have been confirmed as VRE carriers, all without clinical symptoms.

Among the five patients mentioned, two patients are hospitalised at QEH and another two patients were transferred to Kowloon Hospital for further treatment on August 31 and September 6 respectively. They are in stable condition, under medical surveillance and isolation.

One patient succumbed today because of his underlying illness.

The cases have been reported to the Hospital Authority Head Office and the Centre for Health Protection for necessary follow up.

The Hospital Infection Control Team, the department concerned and experts of the Centre for Health Protection had a meeting today and the following enhanced infection control measures have already been adopted:
  1. All VRE carriers are being treated in isolation rooms or cohort according to their clinical symptoms and treatment needs;
  2. Visiting is limited to two people per patient during each visiting period; and
  3. Stringent contact precautions have been applied, including dedicated use of clinical items in respect of VRE carriers, with enhanced hand and environmental hygiene.
The Hospital Infection Control Team will continue to closely monitor the situation of the ward.


Ends/Monday, September 17, 2012
Issued at HKT 18:20
NNNN
-
------
 
Back
Top Bottom